The Current Ratio as of September 2024 (TTM) for Actinium Pharmaceuticals, Inc. (ATNM) is 8.95

According to Actinium Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.95. This represents a change of -7.30% compared to the average of 9.66 of the last 4 quarters.

Actinium Pharmaceuticals, Inc. (ATNM) Historical Current Ratio (quarterly & annually)

How has ATNM Current Ratio performed in the past?

The mean historical Current Ratio of Actinium Pharmaceuticals, Inc. over the last ten years is 6.45. The current 8.95 Current Ratio has changed 13.78% with respect to the historical average. Over the past ten years (40 quarters), ATNM's Current Ratio was at its highest in in the June 2021 quarter at 21.47. The Current Ratio was at its lowest in in the December 2014 quarter at 0.78.

Actinium Pharmaceuticals, Inc. (ATNM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Actinium Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Actinium Pharmaceuticals, Inc. (ATNM) Average Current Ratio

How has ATNM Current Ratio performed in the past?

The current Current Ratio of Actinium Pharmaceuticals, Inc. (ATNM) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Actinium Pharmaceuticals, Inc. (ATNM) Current Ratio vs. Peers

How is ATNM’s Current Ratio compared to its peers?

Actinium Pharmaceuticals, Inc.’s Current Ratio is greater than MiNK Therapeutics, Inc. (0.93), greater than Affimed N.V. (2.71), greater than ImmunoGen, Inc. (5.47), greater than Adaptimmune Therapeutics plc (3.09), greater than Sangamo Therapeutics, Inc. (1.03), greater than Rigel Pharmaceuticals, Inc. (1.62), greater than Fortress Biotech, Inc. (1.37), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than CTI BioPharma Corp. (1.27), less than Ocuphire Pharma, Inc. (10.68), greater than Annovis Bio, Inc. (1.24), greater than Cassava Sciences, Inc. (4.07), greater than Axsome Therapeutics, Inc. (2.48), greater than Seres Therapeutics, Inc. (1.38), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Eyenovia, Inc. (0.43), greater than Cognition Therapeutics, Inc. (3.07), greater than TransCode Therapeutics, Inc. (1.25), less than Kodiak Sciences Inc. (10.59), greater than Exelixis, Inc. (4.27), greater than TG Therapeutics, Inc. (3.58), less than Viking Therapeutics, Inc. (37.69), greater than Madrigal Pharmaceuticals, Inc. (8.72), greater than BioXcel Therapeutics, Inc. (2.35),

Build a custom stock screener for Actinium Pharmaceuticals, Inc. (ATNM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actinium Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Actinium Pharmaceuticals, Inc. (ATNM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Actinium Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.